Eric Stanton Weiss - 22 Sep 2025 Form 4 Insider Report for Kindly MD, Inc. (KDLY)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
24 Sep 2025, 17:34:47 UTC
Prior SEC filing
07 Oct 2025
Next SEC filing
06 Nov 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Kyle Simon, as attorney-in-fact

Key filing fact

Eric Stanton Weiss filed Form 4 for Kindly MD, Inc. (KDLY) on 24 Sep 2025.

Key facts

  • This page summarizes Eric Stanton Weiss's Form 4 filing for Kindly MD, Inc. (KDLY).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 24 Sep 2025, 17:34.

Change

  • Previous filing in this sequence was filed on 07 Oct 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002009491 Primary reporting owner

Weiss Eric Stanton

Relationship
Director
Address
5097 SOUTH 900 EAST, SUITE 100, SALT LAKE CITY
Signature
/s/ Kyle Simon, as attorney-in-fact
Signature date
24 Sep 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NAKA transaction

Common Stock

Award

Transaction value
$0
Shares
+112,781
Change %
Price
$0.000000
Shares after
112,781
Date
22 Sep 2025
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

This reflects restricted stock units ("RSUs") that vest on August 15, 2026 (the "Vesting Date"), subject to the reporting person's continued services on the board of directors of the issuer through the Vesting Date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .